Across TCGA pan-cancer cohorts, RNU6-654P RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated RNU6-654P data layer.
The strongest signal is observed in brain lower grade glioma (LGG), where higher RNU6-654P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-654P expression acts as an unfavorable survival marker.
LGG are the cancer types where RNU6-654P RNA most reproducibly stratifies survival.